Novartis Unveils Path to Becoming a Top 5 US Player by 2027

After months of implementing a major strategic restructuring, Novartis outlined Thursday how it plans to become a top-five player in the United States by 2027.

Novartis executives highlighted how the transformation is nearly complete in a meeting with investors and industry analysts in Switzerland.